Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population-Reference-Cited by-同舟云学术

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population

Published:2021-06 Issue: Volume:Volume 14 Page:2619-2629
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Funch Donnie,Mortimer Kathleen,Ziyadeh Najat J,Seeger John D,Zhou Li,Ng Eva,Ross Douglas,Major-Pedersen Atheline,Bosch-Traberg Heidrun,Gydesen Helge,Dore David

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference37 articles.

1. Victoza. NDA approval. US food and drug administration; 2010. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022341s000approv.pdf. Accessed November 01, 2019.

2. Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation

3. Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland

4. Cancer of the thyroid - cancer stat facts1; 2019. Available from: http://seer.cancer.gov/statfacts/html/thyro.html. Accessed November 01, 2019.

5. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid cancer and insulin resistance;Reviews in Endocrine and Metabolic Disorders;2023-11-14

2. Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?;Endocrine Connections;2023-09-01

3. Semaglutide and cancer: A systematic review and meta-analysis;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-09

4. Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment;Nutrients;2023-08-25

5. Metabolically Healthy Obesity: Are Interventions Useful?;Current Obesity Reports;2023-02-23